Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by cybermanon Jun 18, 2021 12:58pm
202 Views
Post# 33411806

RE:RE:RE:RE:RE:RE:RE:COB sells off a million shares

RE:RE:RE:RE:RE:RE:RE:COB sells off a million sharesoh ya i've seen the gamesmanship, pinksheets, otcbb etc. but i'm betting that's not the case here, i prefer thinking that someone thought they knew something and loaded the dinghy too soon and are prepared to wait it out now.

valid points though, sounds like you're 50 - 50, i think we're worth more, the dilution sucks but thats business and the home office ain't selling, yet anyways !

best.


Righttothetop wrote: The run-ups are likely orchestrated to allow certain investors to exit and/or continue to play the short game.  LABS has been stuck in this trading band for a long while which is totally consistent on it's financials implosion.

It is not getting any love for the groundwork that was done in the years leading up to this and naturally that is taken as an indication that the team can't translate all that partnership fluff into something meaningful.

The solace I take is that a super entity like Stada would not have crawled into bed with a company, that most of the market believes, is useless and incapable of execution.  Dr. Nick in Peru might be given a pass in not researching LABS, but Stada??  Nah, I think they would have done their DD.

Things will ramp up....it's just whether they will ramp up in time.  The longer appointing a CEO takes, the more I think a takeout is coming for pennies....just IMO.

cyberman wrote: of course we'll be the last to know what's really going on but why else the run up recently at close to 48 cents and then 44 cents the other day, seems like word was getting out, my guess is a new CEO announcement, is Bruce Linton still available LOL, seriously, get a BIG name in there already !

until then they are plugging away and seems to have a long term approach, the fact that they ain't bailing out in droves is a good sign, i'll hold.

best of luck.




<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse